Hair Loss News and Research

RSS
Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

Docetaxel decreases the chance of dying by 24 percent in advanced-stage prostate cancer patients resistant to hormone therapy

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

First drug approved for hormone refractory prostate cancer that has shown a survival benefit

Interventional radiologists now are able to treat using minimally invasive procedures

Interventional radiologists now are able to treat using minimally invasive procedures

A booster dose of a substance already found in the body appears to be safe and non-toxic for the treatment of pancreatic cancer

A booster dose of a substance already found in the body appears to be safe and non-toxic for the treatment of pancreatic cancer

New developments in the treatment of pancreatic cancer

New developments in the treatment of pancreatic cancer

Thyroid disorders are often misdiagnosed

Thyroid disorders are often misdiagnosed